• PCMT1 Identified as Metastatic Driver in Ovarian Cancer via

  2026-04-28

  Zhang et al. leveraged a genome-wide CRISPR/Cas9 screen to pinpoint PCMT1 as a pivotal mediator of anoikis resistance and metastatic progression in ovarian cancer. Their mechanistic and in vivo validation highlights PCMT1 as a potential therapeutic target, with broader implications for understanding ECM-driven metastasis.

• 2-Deoxy-D-glucose: Applied Glycolysis Inhibition Workflows

  2026-04-28

  2-Deoxy-D-glucose (2-DG) from APExBIO empowers researchers to dissect cancer metabolism, viral replication, and immunometabolic signaling with quantitative rigor. This guide translates cutting-edge metabolic reprogramming findings into actionable protocols and troubleshooting strategies, ensuring reproducible results in even the most challenging experimental systems.

• G007-LK Tankyrase 1/2 Inhibitor: Practical Insights for Lab

  2026-04-27

  This article provides evidence-based guidance for deploying G007-LK tankyrase 1/2 inhibitor (SKU B5830) in cell viability and pathway modulation assays. Scenario-driven Q&A blocks address experimental challenges, protocol optimization, and product reliability, ensuring researchers can leverage G007-LK for robust Wnt/β-catenin and Hippo pathway research.

• Nitrocefin in β-Lactamase Assays: Precision Tools for Resist

  2026-04-27

  Explore how Nitrocefin, a chromogenic cephalosporin substrate, enables precise and real-time β-lactamase activity measurement for advanced antibiotic resistance research. This article delivers a unique, protocol-focused analysis guiding optimal assay deployment.

• Microbiota–Tryptophan–AhR Axis in Intestinal Repair for UC

  2026-04-26

  Li et al. (2026) reveal that Huangqin decoction (HQD) repairs ulcerative colitis (UC) through a novel microbiota–tryptophan metabolism–AhR–intestinal stem cell axis. Their findings highlight the central role of microbial metabolites in activating aryl hydrocarbon receptor (AhR) signaling, promoting stem cell differentiation, and restoring mucosal integrity—providing new mechanistic insight relevant to both mucosal repair and environmental toxicology research.

• FPH1 (BRD-6125): Optimizing Hepatocyte Proliferation Workflo

  2026-04-25

  FPH1 (BRD-6125) uniquely drives functional, donor-independent expansion of human hepatocytes—crucial for high-throughput drug screening and regenerative medicine. Discover how protocol refinements with APExBIO’s FPH1 unlock reproducible, scalable primary hepatocyte and iHeps cultures.

• Bifendate (DDB): CYP3A4 Modulation and Precision Hepatoprote

  2026-04-24

  Explore Bifendate (DDB) as a hepatoprotection agent with unique CYP3A4 modulation, supported by pharmacogenetic insights. This article reveals how genotype-dependent drug interactions shape experimental and clinical decisions.

• IEM 1460: Redefining AMPA Blockade for Translational Neuropr

  2026-04-24

  This article explores the mechanistic and translational impact of IEM 1460, a selective AMPA receptor blocker, in the context of excitotoxicity, neuroprotection, and advanced assay design. By integrating new evidence from glutamate receptor antagonism and highlighting best practices for translational researchers, it delivers actionable guidance and strategic perspective beyond conventional product literature.

• SLU-PP-332: ERRα/β/γ Agonist and Mitochondrial Biogenesis Ac

  2026-04-23

  SLU-PP-332 is a synthetic ERRα ERRβ ERRγ agonist that robustly stimulates mitochondrial biogenesis and enhances muscle endurance. Peer-reviewed studies confirm nanomolar potency for ERR activation and significant exercise-mimetic effects in vivo. APExBIO supplies SLU-PP-332 as a research-grade, orally bioavailable tool for metabolic and translational research.

• 7ACC2: Potent Monocarboxylate Transporter 1 Inhibitor in Can

  2026-04-23

  7ACC2 is a potent monocarboxylate transporter 1 inhibitor that blocks lactate uptake and mitochondrial pyruvate transport in cancer cells. It demonstrates nanomolar efficacy and dual-acting mechanisms, making it a valuable tool for cancer metabolism research and tumor growth delay studies. All claims are substantiated with peer-reviewed and product-sourced evidence.

• Annexin V, human recombinant: Reliable PS Binding for Apopto

  2026-04-22

  This scenario-driven article addresses common laboratory challenges in apoptosis detection, focusing on how Annexin V, human recombinant (SKU K2064) from APExBIO provides reproducible and data-backed solutions. By grounding every recommendation in evidence—from protocol parameters to vendor selection—this guide optimizes both experimental confidence and workflow efficiency for cell death research.

• Patient-Derived Gastric Cancer Assembloids: Modeling Tumor–S

  2026-04-22

  This study introduces a patient-specific gastric cancer assembloid model that integrates tumor organoids with matched stromal cell subpopulations, closely recapitulating the complexity of the tumor microenvironment. The model reveals how stromal components influence gene expression and drug responses, providing an advanced platform for investigating resistance mechanisms and optimizing personalized therapies.

• PP2A-Driven Autophagy Modulates Candida albicans Biofilm Res

  2026-04-21

  This study establishes that protein phosphatase 2A (PP2A) modulates drug resistance in Candida albicans biofilms by influencing autophagy through ATG protein phosphorylation. The findings highlight a mechanistic link between PP2A activity, biofilm robustness, and antifungal treatment efficacy, offering new avenues for overcoming persistent Candida infections.

• Polymyxin B Sulfate in Precision Immunology: Bridging Infect

  2026-04-21

  Explore how Polymyxin B sulfate, a potent antibiotic, is redefining precision immunology through its dual role in infection research and immune modulation. Discover novel insights that link Gram-negative bacterial targeting to cancer immunotherapy outcomes.

• Perphenazine (SKU B6157): Reliable D2 Antagonist for Cell As

  2026-04-20

  This article guides biomedical researchers through the practical deployment of Perphenazine (SKU B6157) in cell viability, proliferation, and cytotoxicity assays. Using scenario-driven Q&A, it addresses key workflow decisions, protocol optimization, and product selection, offering literature-backed recommendations and protocol parameters to ensure reproducibility and experimental clarity.

436 records 19/30 page Previous Next First page 上5页 1617181920 下5页 Last page